MOMORDICA CHARANTIA
Family: Cucurbitaceae
Native of southern Asia and is common throughout the tropical region of the world. It is an annual climber with Bitter melon fruits muricate, tuberculate, oblong, green and when ripe it turns out to be orange in colour.
Active Principle:
Bitter principles are extracted from the Momordica charantia fruits. The extract provides a non nitrogenous neutral principle, Charantin. It is a hypoglycemic agent composed of mixed steroids. The standardised extract contains 7.5 - 8% Bitter principle and 0.5% of Charantin.
Clinical Uses:
- As a hypoglycemic agent in Diabetes mellitus
- Used as an anti viral
- Anti tumours
Advantages:
- Apart from the anti diabetic properties, Momordica has other biological activities including inhibition of infection and replication of HIV-1.
- No toxic effects were reported.
Products under patent shall not be offered to the market where the intellectual property rights are protected
Disclaimer : These claims have not been evaluated by the Food and Drug Administration. These products are not intended to cure, mitigate, treat or prevent any disease
Phone: 
